Mon, Mar 2, 2015, 3:27 AM EST - U.S. Markets open in 6 hrs 3 mins


% | $
Quotes you view appear here for quick access.

Trius Therapeutics, Inc. (TSRX) Message Board

  • chimakot chimakot Jan 30, 2013 9:18 AM Flag

    Good TSRX read from the street.

    Trius Therapeutics

    Trius Therapeutics (TSRX) is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for serious, life-threatening infections. This stock closed up 7.4% to $5.28 on Tuesday.

    Tuesday's Range: $4.96-$5.29

    52-Week Range: $4.41-$6.49

    Volume: 1.29 million

    Three-Month Average Volume: 382,453

    From a technical perspective, TSRX soared higher here right off its 50-day moving average of $4.97 with monster upside volume. This move filled a previous gap down level from a few weeks ago that started at $5.20. Shares of TSRX are now quickly moving within range of triggering a near-term breakout trade. That trade will hit if TSRX manages to clear its 200-day at $5.37 and then once it takes out more resistance at $5.60 with high volume.

    Traders should now look for long-biased trades in TSRX as long as it’s trending above its 50-day at $4.97 and then once it sustains a move or close above those breakout levels with volume that hits near or above 382,453 shares. If that breakout hits soon, then TSRX will set up to re-test or possibly take out its next major overhead resistance levels at $5.90 to $5.93. Any move above those levels will then put $6.20 to $6.46 into focus for shares of TSRX.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
13.630.0000(0.00%)Sep 11 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.